These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8115415)

  • 61. Effects of monosialoganglioside on dopaminergic supersensitivity.
    Vital MA; Frussa-Filho R; Palermo-Neto J
    Life Sci; 1995; 56(26):2299-307. PubMed ID: 7791517
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Peptide inhibition of morphine-induced dopaminergic supersensitivity.
    Ritzmann RF; Lee JM; Fields JZ
    Life Sci; 1982 Nov 15-22; 31(20-21):2287-90. PubMed ID: 6891737
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
    Rogoza RM; Fairfax DF; Henry P; N-Marandi S; Khan RF; Gupta SK; Mishra RK
    Synapse; 2004 Dec; 54(3):156-63. PubMed ID: 15452862
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of long-term haloperidol treatment on striatal neuropeptides: relation to stereotyped behavior.
    Marin C; Engber TM; Bonastre M; Chase TN; Tolosa E
    Brain Res; 1996 Aug; 731(1-2):57-62. PubMed ID: 8883854
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effects of chronic continuous versus intermittent levodopa treatments on striatal and extrastriatal D1 and D2 dopamine receptors and dopamine uptake sites in the 6-hydroxydopamine lesioned rat--an autoradiographic study.
    Gnanalingham KK; Robertson RG
    Brain Res; 1994 Mar; 640(1-2):185-94. PubMed ID: 8004447
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Phenytoin potentiation of neuroleptic-induced dyskinesias.
    Sethi KD; Hitri A; Diamond BI
    Mov Disord; 1990; 5(4):325-7. PubMed ID: 2147979
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Striatal dopamine receptor supersensitivity after long-term haloperidol treatment of hypophysectomized rats.
    DeLucia R; Scavone C; Camillo MA
    Braz J Med Biol Res; 1989; 22(6):741-3. PubMed ID: 2620186
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Chronic cocaine-induced supersensitivity id blocked by co-treatment with the peptide cyclo-(Leu-Gly).
    Gonzalez LP; Czachura JF; Brewer KW
    NIDA Res Monogr; 1990; 105():353-4. PubMed ID: 1876038
    [No Abstract]   [Full Text] [Related]  

  • 69. Neuroleptic-induced supersensitivity and brain iron: I. Iron deficiency and neuroleptic-induced dopamine D2 receptor supersensitivity.
    Ben-Shachar D; Youdim MB
    J Neurochem; 1990 Apr; 54(4):1136-41. PubMed ID: 1968955
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dopamine receptor 'supersensitivity' occurring without receptor up-regulation.
    Mileson BE; Lewis MH; Mailman RB
    Brain Res; 1991 Oct; 561(1):1-10. PubMed ID: 1686741
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration.
    Clow A; Theodorou A; Jenner P; Marsden CD
    Eur J Pharmacol; 1980 May; 63(2-3):145-57. PubMed ID: 6103814
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Behavioral and biochemical expression of D1-receptor supersensitivity following SCH 23390 repeated administrations.
    Gandolfi O; Roncada P; Dall'Olio R; Montanaro N
    Brain Res; 1988 Jul; 455(2):390-3. PubMed ID: 2969768
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparative effects of Pro-Leu-Gly-NH2 and cyclo(Leu-Gly) administered orally on the development of tolerance to the analgesic effect of morphine in the rat.
    Bhargava HN; Ramarao P
    Peptides; 1989; 10(4):767-71. PubMed ID: 2573893
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of repeated electroconvulsive shocks on dopamine supersensitivity psychosis model rats.
    Kimura M; Oda Y; Oishi K; Yoshino K; Kimura H; Niitsu T; Kanahara N; Shirayama Y; Hashimoto K; Iyo M
    Schizophr Res; 2021 Feb; 228():1-6. PubMed ID: 33429150
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clonazepam improves dopamine supersensitivity in a schizophrenia patient: a case report.
    Fukai M; Hirosawa T; Takahashi T; Kaneda R; Kikuchi M; Minabe Y
    Ther Adv Psychopharmacol; 2017 Mar; 7(3):113-117. PubMed ID: 28348731
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Tardive dyskinesia: a potential new neurochemical animal model.
    Andrade C; Pradhan N
    Indian J Psychiatry; 1990 Jul; 32(3):273-5. PubMed ID: 21927470
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Novel Low-Toxic Derivative of Celastrol Maintains Protective Effect against Acute Renal Injury.
    Hu X; Jia M; Fu Y; Zhang P; Zhang Z; Lin Q
    ACS Omega; 2018 Mar; 3(3):2652-2660. PubMed ID: 30023844
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dyskinesia in multiple system atrophy and progressive supranuclear palsy.
    Jost WH; Lingor P; Tönges L; Schwarz J; Buhmann C; Kassubek J; Schrag A
    J Neural Transm (Vienna); 2019 Jul; 126(7):925-932. PubMed ID: 31087195
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Specific binding of photoaffinity-labeling peptidomimetics of Pro-Leu-Gly-NH2 to the dopamine D2L receptor: evidence for the allosteric modulation of the dopamine receptor.
    Mann A; Verma V; Basu D; Skoblenick KJ; Beyaert MG; Fisher A; Thomas N; Johnson RL; Mishra RK
    Eur J Pharmacol; 2010 Sep; 641(2-3):96-101. PubMed ID: 20639138
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prevention and reversal of dopamine receptor supersensitivity by cyclo(leucyl-glycyl) (CLG): biphasic dose-response curves.
    Drucker GE; Ritzmann RF; Wichlinski LJ; Engh K; Gordon JH; Fields JZ
    Pharmacol Biochem Behav; 1994 Jan; 47(1):141-5. PubMed ID: 8115415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.